JP2024519814A5 - - Google Patents
Info
- Publication number
- JP2024519814A5 JP2024519814A5 JP2023571295A JP2023571295A JP2024519814A5 JP 2024519814 A5 JP2024519814 A5 JP 2024519814A5 JP 2023571295 A JP2023571295 A JP 2023571295A JP 2023571295 A JP2023571295 A JP 2023571295A JP 2024519814 A5 JP2024519814 A5 JP 2024519814A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189522P | 2021-05-17 | 2021-05-17 | |
| US63/189,522 | 2021-05-17 | ||
| PCT/US2022/029535 WO2022245759A2 (en) | 2021-05-17 | 2022-05-17 | Agents for directed conjugation techniques and conjugated products |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024519814A JP2024519814A (ja) | 2024-05-21 |
| JPWO2022245759A5 JPWO2022245759A5 (https=) | 2025-05-23 |
| JP2024519814A5 true JP2024519814A5 (https=) | 2025-05-23 |
Family
ID=84140970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571295A Pending JP2024519814A (ja) | 2021-05-17 | 2022-05-17 | 指向性コンジュゲーション技術のための薬剤及びコンジュゲート生成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240252674A1 (https=) |
| EP (1) | EP4340891A4 (https=) |
| JP (1) | JP2024519814A (https=) |
| KR (1) | KR20240012380A (https=) |
| CN (1) | CN117750979A (https=) |
| AU (1) | AU2022275832A1 (https=) |
| CA (1) | CA3219517A1 (https=) |
| IL (1) | IL307799A (https=) |
| MX (1) | MX2023013272A (https=) |
| PH (1) | PH12023553154A1 (https=) |
| WO (1) | WO2022245759A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3219475A1 (en) * | 2021-05-17 | 2022-11-24 | Wieslaw Kazmierski | Compositions including conjugated therapy enhancers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US20140079636A1 (en) * | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| PL3086814T3 (pl) * | 2013-12-23 | 2020-12-28 | Bayer Pharma Aktiengesellschaft | Koniugaty środka wiążącego (ADC) z inhibitorami KSP |
| WO2017042944A1 (ja) * | 2015-09-10 | 2017-03-16 | 国立大学法人山梨大学 | フィラデルフィア染色体陽性（Ｐｈ＋）急性リンパ性白血病（ＡＬＬ）の治療薬又は治療方法 |
| EP3617235B1 (en) * | 2017-04-28 | 2026-02-18 | Ajinomoto Co., Inc. | Compound having substance that has affinity for soluble protein, cleavable moiety, and reactive group, or salt thereof |
| MX421628B (es) * | 2017-07-26 | 2025-03-14 | Kleo Pharmaceuticals Inc | Compuestos abt universales y usos de los mismos |
| JP7404230B2 (ja) * | 2017-09-18 | 2023-12-25 | トラスティーズ オブ ボストン ユニバーシティ | ネトーシスおよび好中球活性化を処置するための方法 |
| WO2019241609A1 (en) * | 2018-06-15 | 2019-12-19 | Trustees Of Boston University | Polypeptide compositions and methods for site-specific targeting of therapeutic agents |
| AU2020299157A1 (en) * | 2019-07-03 | 2022-01-20 | Kleo Pharmaceuticals, Inc. | CD38-binding agents and uses thereof |
-
2022
- 2022-05-17 US US18/555,857 patent/US20240252674A1/en active Pending
- 2022-05-17 IL IL307799A patent/IL307799A/en unknown
- 2022-05-17 PH PH1/2023/553154A patent/PH12023553154A1/en unknown
- 2022-05-17 KR KR1020237039500A patent/KR20240012380A/ko active Pending
- 2022-05-17 WO PCT/US2022/029535 patent/WO2022245759A2/en not_active Ceased
- 2022-05-17 JP JP2023571295A patent/JP2024519814A/ja active Pending
- 2022-05-17 AU AU2022275832A patent/AU2022275832A1/en active Pending
- 2022-05-17 EP EP22805274.2A patent/EP4340891A4/en active Pending
- 2022-05-17 CA CA3219517A patent/CA3219517A1/en active Pending
- 2022-05-17 CN CN202280034207.3A patent/CN117750979A/zh active Pending
- 2022-05-17 MX MX2023013272A patent/MX2023013272A/es unknown